Premier Research gets bid approach

British pharma Premier Research has some ultra-ambitious managers--they're bidding for a takeover. The company announced that a group of executives has expressed interest in mounting a buyout, making clear it's skeptical that an actual offer will be forthcoming. Just in case, Premier's board has formed an independent committee to consider the bid, if one is eventually made. The company's shares were up 10 percent in early trading.

- read the AFX report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.